Regulation of Nucleoside Transporters by Protein Kinases
Regulation of Nucleoside Transporters by Protein Kinases
批准号:
6924531
负责人:
Lee M Graves
金额:
$29.09万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2008-07-31
关键词:
RNA interferenceapoptosisbiological signal transductioncell differentiationcell proliferationchromatin immunoprecipitationgemcitabinegene expressiongenetic promoter elementgenetic regulationmembrane channelsmitogen activated protein kinasenucleoside analogphosphorylationposttranscriptional RNA processingprotein tyrosine kinaseubiquitin
中文摘要
描述(由申请方提供):平衡型核苷转运蛋白是摄取核苷和化疗核苷类似物(例如Ara-C、吉西他滨)所必需的整合膜蛋白。在联合化疗(即顺铂、放疗)后观察到对核苷类似物的敏感性增强,尽管对这些作用的机制知之甚少。平衡型核苷转运蛋白(ENT 1/2)广泛表达,并根据细胞对有丝分裂原或应激信号的暴露而受到差异调节。目前,控制这些转运蛋白的转录调控的分子事件是未知的。本实验室一直在研究蛋白激酶对嘧啶核苷酸合成的调控。我们最近的研究集中在ENT 1/2在核苷摄取和嘧啶核苷酸补救合成中的需要。具体来说,我们的研究指出了Src和应激激活的c-Jun激酶(JNK)在调节ENT 1/2表达中的关键作用。因此,本提案的目的是表征ENT 1/2的转录调节所必需的激酶依赖性信号,并确定该事件对细胞增殖或存活的影响。此外,我们将确定所需的激酶介导的调节ENT 1/2表达的启动子元件。最后,我们将研究JNK的激活是否参与细胞对核苷类似物的上调和增强的敏感性。该提案的具体目标是:
目标1。确定参与ENT 1/2表达调节的特定蛋白激酶。
目标2。阐明ENT 1和ENT 2表达所必需的启动子元件。
目标3。检查ENT在生长、分化和化学增敏中的特定作用 .
英文摘要
DESCRIPTION (provided by applicant): The equilibrative nucleoside transporters are integral membrane proteins that are essential for the uptake of nucleosides and chemotherapeutic nucleoside analogs (e.g. Ara-C, gemcitabine). Enhanced sensitivity to nucleoside analogs has been observed after combined chemotherapy (i.e. cisplatinum, irradiation), although the mechanism(s) responsible for these effects are poorly understood. The equilibrative nucleoside transporters (ENT1/2) are ubiquitously expressed and are differentially regulated depending on the exposure of cells to mitogens or stress signals. At present, the molecular events that control the transcriptional regulation of these transporters are unknown. Our lab has been investigating the regulation of pyrimidine nucleotide synthesis by protein kinases. Our recent studies have focused on the requirement of ENT 1/2 in the uptake of nucleoside and the salvage synthesis of pyrimidine nucleotides. Specifically our studies have pointed to a crucial role for Src and the stress-activated c-Jun kinases (JNK) in the regulation of ENT1/2 expression. Thus the objective of this proposal is to characterize the kinase-dependent signals that are necessary for the transcriptional regulation of ENT 1/2, and to determine the impact of this event on cell proliferation or survival. In addition, we will determine the promoter elements that are required for kinase-mediated regulation of ENT1/2 expression. Finally, we will investigate whether activation of JNK is involved in the up-regulation and enhanced sensitization of cells to nucleoside analogs. The Specific Aims of the proposal are:
Aim #1. Determine the involvement of specific protein kinases in the regulation of ENT1/2 expression.
Aim #2. Elucidate the promoter elements necessary for the expression of ENT1 and ENT2.
Aim #3. Examine the specific roles of ENTs in growth, differentiation and chemosensitization .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
-
批准号:10256779
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2020
-
负责人:Lee M Graves
-
依托单位:
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
-
批准号:10034106
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2020
-
负责人:Lee M Graves
-
依托单位:
Elucidating the mechanism of action of novel ClpP activators in activation of the mitochondrial unfolded protein response.
-
批准号:10416057
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2020
-
负责人:Lee M Graves
-
依托单位:
Tumor subtypes and therapy response in pancreatic cancer
-
批准号:9336282
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2016
-
负责人:Lee M Graves
-
依托单位:
Tumor subtypes and therapy response in pancreatic cancer
-
批准号:9176967
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2016
-
负责人:Lee M Graves
-
依托单位:
Tumor subtypes and therapy response in pancreatic cancer
-
批准号:9518615
-
项目类别:
-
资助金额:$59.14万
-
财政年份:2016
-
负责人:Lee M Graves
-
依托单位:
Core B Proteomics & Biostatistics
-
批准号:9074406
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2016
-
负责人:Lee M Graves
-
依托单位:
Proteomics Core Facility
-
批准号:8340309
-
项目类别:
-
资助金额:$23.58万
-
财政年份:2011
-
负责人:Lee M Graves
-
依托单位:
Re-activation of maspin tumor suppressor gene by designed transcription factors
-
批准号:8026864
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2007
-
负责人:Lee M Graves
-
依托单位:
Regulation of Nucleoside Transporters by Protein Kinases
-
批准号:7262991
-
项目类别:
-
资助金额:$27.59万
-
财政年份:2004
-
负责人:Lee M Graves
-
依托单位:
Regulation of Nucleoside Transporters by Protein Kinases
-
批准号:6822020
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2004
-
负责人:Lee M Graves
-
依托单位:
Regulation of Nucleoside Transporters by Protein Kinases
-
批准号:7100888
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2004
-
负责人:Lee M Graves
-
依托单位:
REGULATION OF CARBAMYL PHOSPH SYNTHETASES BY MAP KINASE
-
批准号:6181528
-
项目类别:
-
资助金额:$19.66万
-
财政年份:1999
-
负责人:Lee M Graves
-
依托单位:
REGULATION OF CARBAMYL PHOSPH SYNTHETASES BY MAP KINASE
-
批准号:2885124
-
项目类别:
-
资助金额:$22.06万
-
财政年份:1999
-
负责人:Lee M Graves
-
依托单位:
REGULATION OF CARBAMYL PHOSPH SYNTHETASES BY MAP KINASE
-
批准号:6526125
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1999
-
负责人:Lee M Graves
-
依托单位:
REGULATION OF CARBAMYL PHOSPH SYNTHETASES BY MAP KINASE
-
批准号:6386572
-
项目类别:
-
资助金额:$20.24万
-
财政年份:1999
-
负责人:Lee M Graves
-
依托单位:
Proteomics
-
批准号:10089829
-
项目类别:
-
资助金额:$20.13万
-
财政年份:1997
-
负责人:Lee M Graves
-
依托单位:
Proteomics
-
批准号:10320891
-
项目类别:
-
资助金额:$20.13万
-
财政年份:1997
-
负责人:Lee M Graves
-
依托单位:
Proteomics
-
批准号:10534220
-
项目类别:
-
资助金额:$20.13万
-
财政年份:1997
-
负责人:Lee M Graves
-
依托单位:
MITOGEN-ACTIVATED PROTEIN KINASES--REGULATION BY CAMP
-
批准号:2193406
-
项目类别:
-
资助金额:$9.6万
-
财政年份:1996
-
负责人:Lee M Graves
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: